Sort
85,873 grants matching “alzheimers”
Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4
$948,584Robert W. Mahley · Gabaeron, Inc. · R44 · FY2020 · AG
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimer's disease.
$948,518Srikant Rangaraju · Yale University · R01 · FY2025 · AG
Genomic approach to identification of microglial networks involved in Alzheimer disease risk
$948,483Alison M Goate · Icahn School Of Medicine At Mount Sinai · U01 · FY2020 · AG
Optimization of microtubule-stabilizing triazolopyrimidines as therapeutics for Alzheimer's disease and related tauopathies
$948,369Kurt R. Brunden · University Of Pennsylvania · U01 · FY2019 · AG
The roles of basal forebrain neuronal ensembles in top-down attention
$948,277Shih-Chieh Lin · National Institute On Aging · ZIA · FY2013 · AG
Neurodegenerative Mechanisms in Christianson Syndrome and NHE6-Related Disorders
$948,191Eric M Morrow · Brown University · R01 · FY2021 · NS
Neurodegenerative Mechanisms in Christianson Syndrome and NHE6-Related Disorders
$948,191Eric M Morrow · Brown University · R01 · FY2022 · NS
Neurodegenerative mechanisms in Christianson syndrome and NHE6-related disorders
$948,191Eric M Morrow · Brown University · R01 · FY2020 · NS
Epidemiology, Pathophysiology and Treatment of Diabetic Nephropathy
$948,149Robert G Nelson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Roybal Center for Promoting Adherence to Behavior Change and Enhancing Cognitive Function
$948,047David E Conroy · University Of Michigan At Ann Arbor · P30 · FY2025 · AG
Bacterial disruption of neuroimmune pathways in a transparent brain
$948,000Cressida Arianna Madigan · University Of California, San Diego · DP2 · FY2024 · NS
Chemical Control of Misfolded Protein Fate
$948,000Fleur Marcia Ferguson · University Of California, San Diego · DP2 · FY2025 · NS
Cognitive Aging Brain Morphology and Arrhythmias in Hispanics/Latinos: Implications for Prevention and Management of Alzheimer's Disease-Related Dementias
$947,878Lin Yee Chen · University Of Minnesota · R01 · FY2025 · NS
MODELS OF ESTROGEN INTERACTIONS WITH ALZHEIMERS DISEASE
$947,756University Of Southern California · P01 · FY2001 · AG
Clinical Core B
$947,577Douglas R Galasko · University Of California, San Diego · P50 · FY2011 · AG
Core B: University of Kentucky Alzheimer's Disease Core Center
$947,257Gregory A Jicha · University Of Kentucky · P30 · FY2023 · AG
Long Life Family Study: Duke Univ./Univ. of Southern Denmark Field Center
$947,062Kaare Christensen · Duke University · U01 · FY2017 · AG
Genetic Epidemiology of Coronary Artery Disease
$946,940University Of Michigan At Ann Arbor · R01 · FY2002 · HL
Genetic analysis in families with neurological disease
$946,793Andrew Singleton · National Institute On Aging · ZIA · FY2024 · AG
Leptin as a Therapy for Alzheimer's Disease
$946,570Nikolaos Tezapsidis · Neurotez, Inc. · R44 · FY2011 · AG
An Integrated Genomic Approach to Alzheimer Disease
$946,448Duke University · R01 · FY2003 · AG
Alzheimer's Disease Neuroimaging Initiative
$946,418Michael W Weiner · Northern California Institute/Res/Edu · U19 · FY2017 · AG
Engagement in Longevity and Medicine (ELM)
$946,297Joshua Chodosh · New York University School Of Medicine · R24 · FY2020 · AG
Optimization of microtubule-stabilizing triazolopyrimidines as therapeutics for Alzheimer's disease and related tauopathies
$946,116Kurt R. Brunden · University Of Pennsylvania · U01 · FY2020 · AG
MODELS OF ESTROGEN INTERACTIONS WITH ALZHEIMERS DISEASE
$946,115University Of Southern California · P01 · FY2000 · AG